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Abstract 
Background: Chronic consumption of small amounts of ethanol protects myocardium from ischemic injury. We 
tested the hypothesis that adenosine type 1 (A1) receptors mediate these beneficial effects. Methods: Dogs 
(n=37) were fed with ethanol (1.5 g/kg) or water mixed with dry food twice per day for 12 weeks, fasted 
overnight before experimentation, and instrumented for measurement of hemodynamics. Dogs received 
intravenous drug vehicle (50% polyethylene glycol in 0.1 N sodium hydroxide and 0.9% saline over 15 min) or the 
selective A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, 0.8 mg/kg over 15 min) and were 
subjected to a 60 min coronary artery occlusion followed by 3 h of reperfusion. Myocardial infarct size and 
transmural coronary collateral blood flow were measured with triphenyltetrazolium chloride staining 
and radioactive microspheres, respectively. Results: The area at risk (AAR) for infarction was similar between 
groups. Pretreatment with ethanol significantly reduced infarct size to 13±2% (n=7) of the AAR as compared to 
control experiments (26±2%; n=7). DPCPX abolished the protective effects of ethanol pretreatment 
(30±3%; n=7) but had no effect in dogs that did not receive ethanol (25±2%; n=7). No differences in transmural 
coronary collateral blood flow were observed between groups. Conclusions: The present findings indicate that 
chronic ingestion of small amounts of ethanol produces myocardial protection that persists after the 
discontinuation of ethanol. The results indicate that A1 receptors mediate ethanol-induced preconditioning in 
dogs independent of alterations in systemic hemodynamics or coronary collateral blood flow. 
Keywords 
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1. Introduction 
Chronic consumption of small amounts of ethanol improves survival in patients after acute myocardial 
infarction [1], [2], but the mechanisms responsible for this beneficial effect are incompletely described. 
We [3], [4] and others [5] have recently demonstrated that chronic, moderate ethanol consumption preserves 
myocardium from irreversible ischemic damage by activation of mitochondrial adenosine triphosphate-
dependent potassium (KATP) channels, a process that we termed ‘chronic ethanol-induced preconditioning’ 
(CEPC). Mitochondrial KATP channels [6] also mediate the protective effects of ischemic preconditioning (IPC) 
through an intracellular signal transduction pathway that includes adenosine type 1 (A1) receptors [7] coupled to 
inhibitory guanine (Gi) nucleotide binding proteins [8] and protein kinase C (PKC) [9]. 
Evidence initially obtained in isolated guinea pig and rat hearts indicates that chronic exposure to small amounts 
of ethanol protects myocardium from subsequent ischemic injury by a signal transduction pathway similar to 
that implicated in IPC [10], [11], [12]. The salutary action of chronic ingestion of low doses of ethanol was 
attributed to activation of adenosine or alpha-adrenergic receptors [10], [12] and sustained translocation of the 
epsilon isoform of PKC [11]. However, hemodynamics and regional myocardial perfusion were not quantified nor 
were plasma ethanol concentrations assessed in these previous studies [10], [11], [12]. In contrast, 
we [3], [4] have employed a unique canine model of intermittent ethanol ingestion during the pretreatment 
period [13] that more closely resembles moderate ethanol consumption with meals in humans and consistently 
produces subintoxicating plasma ethanol concentrations [3]. Acute experimentation after ethanol pretreatment 
in this large animal model allows invasively-derived assessment of systemic hemodynamics and precise 
quantification of coronary collateral blood flow before and during prolonged coronary artery occlusion and 
reperfusion in vivo. In the present investigation, we tested the hypothesis that A1 receptors mediate the 
protective effects of chronic intermittent ingestion of ethanol independent of alterations in hemodynamics or 
transmural myocardial perfusion. 
2. Methods 
All experimental procedures and protocols used in this investigation were reviewed and approved by the Animal 
Care and Use Committee of the Medical College of Wisconsin. All conformed to the Guiding Principles in the 
Care and Use of Animals of the American Physiological Society and the Guide for the Care and Use of Laboratory 
Animals of the National Institutes of Health (Revised, 1996). 
2.1. General preparation 
Mongrel dogs weighing between 25 and 30 kg were randomly assigned to receive dry dog chow (Lab Canine 
Diet, Richmond, IN) mixed with ethanol (1.5 g/kg) or an equal volume of water twice a day for 12 
weeks [3], [4], [13]. Drinking water was provided ad libitum. We [3] have previously shown that administration 
of ethanol using this method produces peak blood ethanol concentrations of 52±4 mg/dl 45 min after eating. 
Dogs that did not consume the chow–ethanol mix or lost weight during the 12 week pretreatment period were 
excluded from further experimentation. Dogs were fasted overnight before and did not receive ethanol on the 
day of experimentation. 
2.2. Implantation of instruments 
Dogs were anesthetized with sodium barbital (200 mg/kg) and sodium pentobarbital (15 mg/kg) and ventilated 
with an air and oxygen mixture (fraction of inspired oxygen=0.25) after intubation of the trachea as previously 
described [3], [14]. Acid–base status and arterial blood gas tensions were maintained within the normal range by 
adjustment of respiratory rate and tidal volume throughout the experiment. After calibration, a double pressure 
transducer-tipped catheter was inserted into the aorta and left ventricle (LV) through the left carotid artery to 
measure arterial and LV pressures. The maximal rate of increase of LV pressure (+dP/dtmax) was obtained by 
electronic differentiation of the LV pressure wave form. The femoral artery and vein were cannulated for the 
withdrawal of reference blood flow samples and fluid administration, respectively. A thoracotomy was 
performed in the left fifth intercostal space. A heparin-filled catheter was inserted into the left atrial appendage 
for administration of radioactive microspheres. A 1.0 cm segment of the left anterior descending coronary artery 
(LAD) was dissected immediately distal to the first diagonal branch, and a silk ligature was placed around this 
vessel for production of coronary artery occlusion and reperfusion. The appearance of cyanosis and regional 
dyskinesia of myocardium immediately distal to the ligature were used to verify the adequacy of LAD occlusion 
in all experiments. Hemodynamic data were continuously monitored throughout the experiment, recorded on a 
polygraph, and digitized using a computer interfaced with an analog-to-digital converter. 
2.3. Measurement of myocardial infarct size 
At the conclusion of each experiment, the LAD was again occluded and cannulated at the occlusion site [14]. 
Briefly, 10 ml each of saline and patent blue dye were injected at equal pressure in the LAD and left atrium to 
delineate the anatomic area at risk (AAR) and the normal zone, respectively. The heart was fibrillated, removed, 
and sliced into serial 6 to 7 mm wide transverse sections. The unstained AAR was separated from the normal 
area, and the two regions were incubated for 20 min at 37 °C in 1% 2,3,5-triphenyltetrazolium chloride in 0.1 M 
phosphate buffer adjusted to pH=7.4. Infarcted and noninfarcted myocardium within the AAR were separated 
and weighed after being stored overnight in 10% formaldehyde. Infarct size was expressed as a percentage of 
AAR. 
2.4. Measurement of regional myocardial perfusion 
Carbonized plastic microspheres [15±2 μm (SD)] labeled with 95Nb, 141Ce, and 103Ru were used to measure 
myocardial perfusion as previously described [14]. Briefly, microspheres were administered into the left atrium 
as a bolus and flushed in with 10 ml of warm (37 °C) saline. A few seconds before injection, a timed collection of 
reference arterial blood flow was started from the femoral arterial catheter at a rate of 7 ml/min for 3 min. 
Microspheres were injected 5 min before LAD occlusion (after administration of vehicle or DPCPX), 30 min after 
LAD occlusion, and 1 h after final reperfusion. Transmural tissue samples were selected from the ischemic region 
and subdivided into subepicardial, midmyocardial, and subendocardial layers of approximately equal thickness. 
Samples were weighed and placed in scintillation vials, and the activity of each isotope was determined. 
Similarly, the activity of each isotope in the reference blood flow sample was assessed. Tissue blood flow 
(ml/min per g) was calculated as Qr·Cm/Cr, where Qr is the rate of withdrawal of the reference blood flow sample 
(ml/min), Cm is the activity (cpm/g) of the myocardial tissue sample, and Cr is the activity of the reference blood 
flow sample. Transmural blood flow was considered to be the average of the subepicardial, midmyocardial, and 
subendocardial blood flows. 
2.5. Experimental protocol 
Baseline hemodynamics were recorded 90 min after completion of the surgical preparation. All dogs were 
subjected to a 60 min LAD occlusion followed by 3 h of reperfusion. In four separate groups of experiments, 
dogs that consumed ethanol or water (control) mixed with dog chow for 12 weeks were randomly assigned to 
receive intravenous infusions of drug vehicle (50% polyethylene glycol in 0.1 N sodium hydroxide and 0.9% 
saline over 15 min) or the selective A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 0.8 mg/kg 
over 15 min) 60 min before LAD occlusion and reperfusion. We have previously shown that this dose of DPCPX 
markedly attenuates enhanced functional recovery of stunned myocardium produced by the volatile anesthetic 
isoflurane in dogs [15]. Dogs that developed intractable ventricular fibrillation and those with a subendocardial 
coronary collateral blood flow=0.15 ml/min per g were excluded from subsequent data analysis [16]. 
2.6. Statistical analysis 
Statistical analysis of data within and between groups was performed with analysis of variance (ANOVA) with 
repeated measures followed by Student’s t-test with Bonferroni’s correction for multiplicity. Linear regression 
analysis was performed to determine the relationship between transmural collateral blood flow and myocardial 
infarct size. Changes within and between groups were considered statistically significant when P<0.05. Data are 
expressed as mean±standard error of the mean (S.E.M.). 
3. Results 
All dogs consumed the assigned diet during the 12 week pretreatment period. Thirty seven dogs were used to 
obtain 28 successful experiments. Four dogs were excluded from analysis because of intractable ventricular 
fibrillation during LAD occlusion or reperfusion (1 control, 2 ethanol pretreatment alone, 1 ethanol pretreatment 
and DPCPX). Five dogs were excluded because subendocardial coronary collateral blood flow exceeded 0.15 
ml/min/g (1 control, 1 DPCPX alone, 1 ethanol pretreatment alone, 2 ethanol pretreatment and DPCPX). 
No differences in baseline systemic hemodynamics were observed between experimental groups (Table 1). 
Table 1. Systemic hemodynamics  
Baseline Vehicle Coronary Reperfusion (min)     
or OPCPX occlusion 60 120 180 
HR (min−1) 
      
Vehicle 128±4 128±4 117±7 117±6 120±4 122±5 
DPCPX 129±7 126±7 127±5 126±3 126±5 121±6 
Ethanol+vehicle 127±4 127±4 121±4 117±4 118±4 119±6 
Ethanol+DPCPX 134±4 132±5 133±5 123±4 126±4 127±4 
 
MAP (mmHg) 
      
Vehicle 104±3 104±3 88±3* 95±7 98±5 97±4 
DPCPX 109±3 110±3 89±3* 90±2* 89±3* 91±2* 
Ethanol+vehicle 111±6 111±6 97±7 96±6* 100±5 101±5 
Ethanol+DPCPX 107±3 112±4 90±5 85±5* 92±6 94±4 
 
LVSP (mmHg) 
      
Vehicle 117±3 117±3 93±4* 100±7 104±6 102±5 
DPCPX 120±3 122±4 96±3* 93±3* 90±4* 96±2* 
Ethanol+vehicle 122±7 122±7 105±6* 99±5* 104±4* 106±4* 
Ethanol+DPCPX 118±4 125±4 84±6 87±6* 95±7* 98±5 
 
LVEDP (mmHg) 
      
Vehicle 6±1 6±1 11±2* 15±2* 14±2* 15±1* 
DPCPX 5±1 6±1 15±3* 13±2* 11±3 12±3 
Ethanol+vehicle 7±1 7±1 11±2* 8±2 9±2 8±2 
Ethanol+DPCPX 5±1 6±1 15±2* 17±2* 18±2* 14±2* 
 
+dP/dtmax (mmHg·s−1) 
      
Vehicle 1892±159 1892±159 1561±53 1445±70 1504±108 1279±55* 
DPCPX 1967±120 1927±114 1530±72* 1576±51* 1555±59* 1456±70* 
Ethanol+vehicle 1921±172 1921±172 1484±172* 1366±83* 1337±102* 1435±84* 
Ethanol+DPCPX 1922±111 1915±118 1663±191 1362±107* 1470±103* 1480±99* 
Data are mean±SEM; n=7 in each group. 
*Significantly (P<0.05) different from vehicle or DPCPX. 
Abbreviations: HR=heart rate; MAP=mean artorial pressure; LVSP and LVEDP=left ventricular systolic and end-
diastolic pressures, respectively; +dP/dtmax=peak rate of increase of left ventricular pressure; DPCPX=8-
cyclopentyl-1,3-dipropylxanthine. 
 
Twice daily consumption of ethanol for 12 weeks did not affect baseline systemic hemodynamics. Intravenous 
administration of drug vehicle or DPCPX in the presence or absence of ethanol pretreatment was also devoid of 
hemodynamic effects. Significant (P<0.05) increases in LV end-diastolic pressure and decreases in mean arterial 
and LV systolic pressures and LV+dP/dtmax were observed during LAD occlusion and reperfusion. Heart rate was 
unchanged during LAD occlusion and reperfusion. No differences in systemic hemodynamics were observed 
between groups during occlusion or reperfusion. 
The AAR was similar between groups (vehicle 40±1; DPCPX 42±3; ethanol pretreatment and vehicle 40±2; 
ethanol pretreatment and DPCPX 42±2% of the LV). Twelve week pretreatment with ethanol significantly 
reduced myocardial infarct size to 13±2% of the AAR (Fig. 1, Fig. 2) as compared to control experiments (26±2%). 
 
Fig. 1. Myocardial infarct size (IF) expressed as a percentage of the area of the left ventricle at risk (AAR). 
Abbreviation: DPCPX=8-cyclopentyl-1,3-dipropylxanthine. *Significantly (P<0.05) different from VEHICLE; 
†Significantly (P<0.05) different from DPCPX; §Significantly (P<0.05) different from ETHANOL+DPCPX. 
 
 
Fig. 2. Relationship between myocardial infarct size (IF) expressed as a percentage of the left ventricular area at 
risk (AAR) and transmural coronary collateral blood flow in dogs receiving VEHICLE (open circles), DPCPX (8-
cyclopentyl-1,3-dipropylxanthine; open squares), ETHANOL+VEHICLE (solid circles), or ETHANOL+DPCPX (solid 
squares). Regression relationships between IF/AAR and collateral flow are illustrated for VEHICLE (line with short 
dashes; y=25.6x+23.9, r=0.21; P=NS), DPCPX (dash-dot line; y=37.1x+24.5, r=0.12; P=NS), ETHANOL+VEHICLE 
(solid line; y=−55.8x+15.8, r=−0.39; P<0.05), and ETHANOL+DPCPX (line with long 
dashes; y=−94.5x+35.4, r=−0.38; P<0.05). Note that the ETHANOL+VEHICLE regression line is shifted downward 
(P<0.05) compared with the regression lines for VEHICLE, DPCPX, and ETHANOL+DPCPX. 
 
DPCPX abolished the protective effects of ethanol pretreatment (30±3%) but had no effect in dogs that did not 
receive ethanol (25±2%). Chronic intermittent ethanol ingestion for 12 weeks did not affect baseline regional 
myocardial perfusion. No differences in transmural coronary collateral blood flow (Table 2) were observed 
between groups. 
Table 2. Transmural myocardial blood flow in the ischemic and normal regions (ml/min/g) 
 
Vehicle Coronary Reperfusion  
of DPCPX occlusion 
 
Ischemic region 
   
Vehicle 1.08±0.11 0.08±0.01* 1.22±0.14 
DPCPX 1.25±0.20 0.04±0.01* 1.58±0.31 
Ethanol+vehicle 0.88±0.15 0.05±0.01* 0.90±0.11 
Ethanol+DPCPX 0.80±0.05 0.06±0.01* 1.00±0.15 
 
Normal region 
   
Vehicle 1.22±0.11 1.12±0.11 1.23±0.14 
DPCPX 1.55±0.27 1.21±0.24 1.47±0.30 
Ethanol+vehicle 1.34±0.17 0.98±0.14 0.94±0.11 
Ethanol+DPCPX 1.05±0.16 0.93±0.11 1.18±0.14 
Data are mean±SEM; n=7 in each group. 
*Significantly (P<0.05) different from vehicle or DPCPX. 
Abbreviation: DPCPX=8-cyclopentyl-1,3-dipropylxanthine. 
 
4. Discussion 
Previous investigations from this [3], [4] and other laboratories [5], [10], [11], [12], [17] have demonstrated that 
chronic, moderate ethanol consumption protects myocardium from ischemic injury in isolated and intact hearts. 
The results of these experiments obtained in several animal species are supported by recent clinical 
observations that chronic ingestion of small amounts of ethanol enhances survival after myocardial infarction in 
humans [1], [2]. The precise mechanisms responsible for this beneficial effect remain to be completely defined, 
but a signal transduction cascade has been implicated in CEPC that is remarkably similar to a major pathway 
responsible for IPC. The present results confirm the previous findings indicating that chronic, intermittent 
ethanol ingestion reduces the extent of myocardial infarction associated with prolonged coronary artery 
occlusion and reperfusion. The reduction in infarct size produced by chronic ethanol ingestion observed in dogs 
in the present and previous studies [3], [4] occurred independent of alterations in systemic hemodynamics and 
coronary collateral blood flow. Other studies conducted in rats [5], [12], [17] and guinea pigs [10], [11], [12] did 
not quantify transmural myocardial perfusion during experimentation or measure blood ethanol concentrations 
during pretreatment. Although we did not specifically determine blood ethanol concentrations during ethanol 
pretreatment in the present investigation, we have previously demonstrated that administration of ethanol 
using the methods described produces subintoxicating peak blood ethanol concentrations [3], [4]. 
The present results also demonstrate that the beneficial effect of ethanol was blocked by administration of the 
selective A1 antagonist DPCPX before LAD occlusion, suggesting that CEPC is mediated by A1 receptors in dogs. 
These findings support and extend the results of Miyamae et al. [10], [12] that also demonstrated a role for 
adenosine receptors in chronic ethanol-induced protection against myocardial ischemic injury. Isolated hearts 
from guinea pigs exposed to low concentrations (2.5 or 5%) of ethanol in their drinking water for 12 weeks 
before experimentation demonstrated improved functional recovery (peak developed LV pressure) and 
decreased myocardial necrosis (creatine kinase release) after 45 min of no-flow ischemia as compared with 
controls [10], [12]. These salutary effects were inhibited by the nonselective adenosine receptor antagonist 8-(p-
sulfophenyl)theophylline (SPT) and DPCPX but not by the selective A2 antagonist 3,7-dimethyl-1-
propargylxanthine (DMPX) [10], [12]. The results with a 12 week exposure to ethanol were similar to those 
obtained with IPC produced by 2 min of global ischemia followed by 5 min of reperfusion before no-flow 
ischemia in the absence of ethanol pretreatment. The present and previous [10], [12] results are also partially 
supported by recent findings demonstrating that adenosine-induced myocardial protection against excessive 
catecholamine stimulation may be enhanced by chronic ethanol consumption in rats [18]. Hearts chronically 
exposed to ethanol demonstrated increased sensitivity to the protective effects of adenosine despite reductions 
in total myocardial adenosine release measured in coronary venous blood. These findings suggested that chronic 
ethanol ingestion may produce an upregulation or enhanced responsiveness of myocardial adenosine 
receptors [18]. Such phenomena may be associated with increased myocardial protection against ischemic injury 
because of the well-established link between A1 receptors and KATP channels [7], [19]. This intriguing hypothesis 
will require additional research to confirm, however. Extrapolation of the conclusions of Fenton and 
Chung [18] to the present results should also be qualified because larger amounts of ethanol (36% of total daily 
caloric intake) were chronically ingested for a more prolonged duration (8 months) by rats in this previous study. 
Whether administration of DPCPX during the preconditioning period prevents the development of CEPC also 
remains unknown. 
In contrast to the continuous administration of ethanol in drinking water described in many previous 
studies [5], [10], [11], [12], [17], the present investigation used intermittent administration of ethanol with ad 
libitum access to fresh drinking water during the pretreatment period. Myocardial protection associated with 
this method of administration occurred after ethanol had been withheld the night before experimentation, in 
contrast to the presence of an average blood ethanol concentration of 3 mM immediately before 
experimentation previously described in one study [5]. Acute exposure to ethanol concentrations as low as 10 
mM has been shown to produce direct protective effects against ischemic damage in ventricular myocytes and 
isolated hearts [20], [21] and enhance the functional recovery of stunned myocardium in vivo [22]. There is also 
experimental evidence in neural tissue indicating that acute administration of ethanol may directly activate 
A1 receptors [23] by increasing the extracellular concentration of adenosine [24]. Thus, it remains possible that 
previous results implicating the A1 receptor in CEPC obtained in small mammals continuously exposed to ethanol 
may have been influenced to some degree by the presence of ethanol immediately before experimentation. 
However, acute administration of intoxicating doses of ethanol immediately before coronary artery occlusion 
did not reduce infarct size in similar canine model [25]. These findings suggest that chronic ethanol ingestion 
may be required for myocardial protection to occur. 
The present results should be interpreted within the constraints of several potential limitations. The specificity 
of DPCPX for the A1 receptor has not been definitively established in canine myocardium, but this compound has 
been shown to be 700 times more selective for A1 versus A2 receptors using radioligand binding studies and in 
vitro functional assays [26]. Previous studies also indicate that the dose of DPCPX (0.8 mg/kg) used in the 
present investigation attenuates isoflurane-induced improvements in the functional recovery of stunned 
myocardium [15] and abolishes IPC in the canine heart [19] via A1 receptor blockade. It is unlikely that 
myocardial protection produced by chronic, intermittent ethanol ingestion and the abolition of this beneficial 
effect by DPCPX were related to differential alterations in myocardial oxygen consumption because systemic 
hemodynamics were very similar between experimental groups. Nevertheless, coronary sinus oxygen tension 
was not specifically measured and myocardial oxygen consumption was not directly calculated in the present 
investigation. Whether DPCPX acutely alters the well-known beneficial effects of chronic, intermittent ethanol 
ingestion on platelet function and lipid metabolism also cannot be completely excluded as a potential 
explanation for observed findings. The present results also require qualification because oral ingestion of the 
dose of ethanol used in this investigation may produce greater blood ethanol concentrations in humans than 
dogs, although the pharmacokinetics of ethanol appear to be relatively similar between these species. 
In summary, the present results demonstrate that chronic, intermittent consumption of small amounts of 
ethanol reduce myocardial infarct size in dogs independent of alterations in hemodynamics or transmural 
myocardial perfusion. This protective effect was abolished by the selective A1 antagonist DPCPX, indicating that 
the A1 receptor mediates CEPC in vivo. 
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